Biolase stock forecast.

Jul 26, 2023 · Shortly following the special meeting, the Board of Directors exercised such discretion to effect a 1-for-100 reverse stock split that will become effective at 11:59 p.m. Eastern Time on July 27, 2023, and the Company's common stock will begin trading on a split-adjusted basis at the opening of the market on July 28, 2023. How much is Biolase stock worth today? ( NASDAQ: BIOL) Biolase currently has 2,296,777 outstanding shares. With Biolase stock trading at $1.25 per share, the total value of Biolase stock (market capitalization) is $2.87M. Biolase stock was originally listed at a price of $38,049.71 in Dec 31, 1997. 4 ago 2023 ... When compared to a stock's price action, it can give traders a better ... Biolase reported a 1-for-100 reverse stock split. The company's ...BIOLASE is a company that develops and sells laser systems for dental procedures. The stock has a consensus rating of Buy and a price target of $513.50, with a forecasted upside of 30,132.6%. The company reported record revenue and earnings in the second quarter of 2023, and announced a public offering of preferred stock and warrants.

Nov 30, 2023 · BIOLASE stock has a strong buy rating from 3 analysts, who predict an increase of 6,566.47% to $113.33 in the next 12 months. The average price target is $100, with a range of $40 to $200. The stock has a low revenue growth rate and a high EPS loss in the past year. Biolase Stock (NASDAQ:BIOL), Analyst Ratings, Price Targets, Predictions. Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand ...

It's typically categorized as a valuation metric and is most often quoted as Cash Flow per Share and as a Price to Cash flow ratio. In this case, it's the cash flow growth that's being looked at ...The Series H Convertible Preferred Stock has a term of two (2) years and is convertible at the option of the holder at any time into shares of BIOLASE common stock at a conversion price of $0.1398.

Nov 27, 2023 · The Biolase stock price fell by -6.45% on the last day (Monday, 27th Nov 2023) from $1.24 to $1.16. During the last trading day the stock fluctuated 10.00% from a day low at $1.10 to a day high of $1.21. The price has been going up and down for this period, and there has been a 0.87% gain for the last 2 weeks. The Series H Convertible Preferred Stock has a term of two (2) years and is convertible at the option of the holder at any time into shares of BIOLASE common stock at a conversion price of $0.1398.BIOLASE Stock Earnings. The value each BIOL share was expected to gain vs. the value that each BIOL share actually gained. BIOLASE ( BIOL) reported Q2 2023 earnings per share (EPS) of -$8.93, missing estimates of -$5.33 by 67.48%. In the same quarter last year, BIOLASE 's earnings per share (EPS) was -$90.62. BIOLASE is expected to release next ...Stock BIOL November 24, 2023 NASDAQ 20 minutes delay $1.22 Open 1.27 Low ... BIOLASE is the global market leader in all-tissue & soft-tissue dental laser systems that are #AdvancingDentistry ...WebThe medical device company, Biolase ( NASDAQ: BIOL) has lost ~17% in the pre-market Friday as its shares begin trading on a split adjusted basis after the company’s shareholders approved a ...Web

BIOLASE released very strong preliminary Q4 top-line numbers with revenues now eclipsing pre-COVID numbers. Read here to learn more about BIOL's stock outlook.Web

Proceeds from the sale of common stock and pre-funded warrants. 8,503 — Proceeds from the exercise of common stock warrants. 14 — Net cash and cash equivalents provided by financing activities ...

Biolase price target lowered to $3.00 from $5.00 at Maxim November 15, 2023TipRanks. Positive Clinical Trial Results and Successful Cost Optimization Initiatives Bolster Buy Rating for Biolase ...See the latest Applied Therapeutics Inc stock price (APLT:XNAS), related news ... BIOLASE? PR Newswire Nov 8, 2023 6:31am · Thinking about buying stock in ...The 12-month stock price forecast is $113.33, which is an increase of 9,594.61% from the latest price. Price Target ( 9,594.61% upside) Analyst Consensus: Strong Buy News All Videos Press Releases ConversationAnalyzing the anticipated performance of BIOLASE, the ceiling value that the stock is expected to reach in 2025 stands at a promising $2.56.Indicating a bullish trend, an upside potential of 49.75% signals profitable prospects, with an average monthly return of 1.91%, beckoning investors to consider amplifying their portfolios.The 12-month stock price forecast is $113.33, which is an increase of 9,594.61% from the latest price. Price Target ( 9,594.61% upside) Analyst Consensus: Strong Buy News All Videos Press Releases ConversationInvestors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...

SOFT TISSUE LASERS. "From a business perspective, the BIOLASE laser has grown our practice tremendously. We’ve incorporated so many new patients into our practice. They come by word-of-mouth, they come just wanting a laser experience, and I’ve doubled my production on a daily basis." Explore the latest dental laser technology with BIOLASE ...WebStock Price Forecast. According to 33 stock analysts, the average 12-month stock price forecast for Apple stock is $197.09, which predicts an increase of 3.05%. The lowest target is $120 and the highest is $240. On average, analysts rate Apple stock as …WebThe Biolase Inc (BIOL) stock price forecast for the next 12 months is generally positive, with an average analyst price target of $21.75, representing a +1,639% increase from the current price of $1.2506. The highest analyst price target is $42.41, and the lowest is $1.0934.Open 1.27 Prior Close 1.22 (11/22/23) 1 Day BIOL 1.64% DJIA 0.33% Russell 2K 0.67% Health Care/Life Sciences 0.32% Overview Per-Share Earnings, Actuals & Estimates Biolase Inc. QuarterlyGet the latest news and real-time alerts from BIOLASE, Inc. (BIOL) stock at Seeking Alpha. ... Biolase gains after forecasting strong near-term outlook SA News Thu, Aug. 12, 2021.

Dec 1, 2023 · Full Company Report for BIOL. View Biolase, Inc BIOL investment & stock information. Get the latest Biolase, Inc BIOL detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

BIOLASE Inc. Announces Pricing of $4.5 Million Underwritten Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants PR Newswire - Wed Sep 13, 10:16PM CDT. /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten...Dec 1, 2023 · Full Company Report for BIOL. View Biolase, Inc BIOL investment & stock information. Get the latest Biolase, Inc BIOL detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Shortly following the special meeting, the Board of Directors exercised such discretion to effect a 1-for-100 reverse stock split that will become effective at 11:59 p.m. Eastern Time on July 27, 2023, and the Company's common stock will begin trading on a split-adjusted basis at the opening of the market on July 28, 2023.Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.Based on 2 Wall Street analysts offering 12 month price targets for Biolase in the last 3 months. The average price target is $4.00 with a high forecast of $4.00 and a low forecast of $4.00. The average price target represents a 244.83% change from the last price of $1.16. Highest Price Target $4.00. Average Price Target $4.00. A high-level overview of BIOLASE, Inc. (BIOL) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.The forecast for beginning of March 511. Maximum value 527, while minimum 467. Averaged NVIDIA stock price for month 501. Price at the end 497, change for March -2.74%. NVIDIA Stock Forecast For Tomorrow, Week, Month. Netflix Stock Forecast 2023, 2024, 2025. NVIDIA stock price predictions for April 2024. The forecast for beginning of …WebThe Wall Street analyst predicted. that Biolase's share price could reach $40.00 by May 31, 2024. The average Biolase stock price prediction forecasts a potential upside of 3,125.81% from the current BIOL share price of $1.24. ©Biolase Company Info. BIOLASE, Inc. is a medical device company, which engages in the developing, manufacturing, marketing and sale of laser systems in dentistry and medicine. It operates through ...WebGet the latest news and real-time alerts from BIOLASE, Inc. (BIOL) stock at Seeking Alpha. ... Biolase gains after forecasting strong near-term outlook SA News Thu, Aug. 12, 2021.

The Biolase stock holds buy signals from both short and long-term moving averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is …Web

The Series H Convertible Preferred Stock has a term of two (2) years and is convertible at the option of the holder at any time into shares of BIOLASE common stock at a conversion price of $0.1398.

Biolase Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... The Barchart Technical Opinion rating is a 100% Sell with a Weakening short term outlook on maintaining the current direction. Long term indicators fully support a continuation of the trend. See More Share. BIOL ...WebBIOLASE, Inc. (BIOL) is a global leader in dental lasers, trading on NasdaqCM. The stock price, news, quote and history of BIOLASE, Inc. (BIOL) are available on Yahoo Finance. See the latest performance outlook, earnings date, dividend yield, research reports and more. View the latest Biolase Inc. (BIOL) stock price, news, historical charts, analyst ratings and financial information from WSJ.Nov 30, 2023 · BIOLASE stock has a strong buy rating from 3 analysts, who predict an increase of 6,566.47% to $113.33 in the next 12 months. The average price target is $100, with a range of $40 to $200. The stock has a low revenue growth rate and a high EPS loss in the past year. BIOLASE tomorrow. We’ve gathered insights from a variety of expert analysts and amalgamated them to present an integrated daily outlook for BIOLASE shares for the forthcoming month. The nature of short-term forecasts often leads to a decrease in precision, attributed to the myriad of elements at play in the volatile financial markets.Based on 3 Wall Street analysts offering 12 month price targets for Biolase in the last 3 months. The average price target is €0.25 with a high forecast of €0.36 and a low forecast of €0.09. The average price target represents aGet the latest BIOLASE, Inc. (BIOL) stock news and headlines to help you in your trading and investing decisions.The Series H Convertible Preferred Stock has a term of two (2) years and is convertible at the option of the holder at any time into shares of BIOLASE common stock at a conversion price of $0.1398.While BIOLASE's business continues to show respectable growth, cash burn remains a major issue. Click here to find out why investors should continue to avoid BIOL stock.Nov 26, 2023 · BIOLASE, Inc. (BIOL) share price prediction for 2023, 2024, 2025, 2026 and 2027. BIOL one year forecast. Biolase stock monthly and weekly forecasts. Biolase, Inc. Common Stock (BIOL) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

Biolase, Inc. BIOLNASDAQ BIOLNASDAQ 1.24USD +0.02 +1.64% At close at Nov 24, 13:47 UTC-8 See on Supercharts Overview News Ideas Financials Technicals Forecast …Wall Street Stock Market & Finance report, prediction for the future: You'll find the Assertio Holdings share forecasts, stock quote and buy / sell signals below. According to present data Assertio Holdings's ASRT shares and potentially its market environment have been in bearish cycle last 12 months (if exists).The medical device company, Biolase ( NASDAQ: BIOL) has lost ~17% in the pre-market Friday as its shares begin trading on a split adjusted basis after the company’s shareholders approved a ...US0909117022. BIOLASE, Inc. is a medical device company, which engages in the developing, manufacturing, marketing and sale of laser systems in dentistry and medicine. It operates through the Waterlase (all-tissue) systems, and Diode (soft-tissue) systems products. The Waterlase systems use a patented combination of water and laser energy to ... Instagram:https://instagram. female 100best car insurance in nj for new driverswho has the best boat insuranceforex brokers hedging allowed BIOLASE is the world’s leading innovator in dental lasers. Our state-of-the-art dental lasers deliver unparalleled precision, efficiency, and patient comfort with minimally invasive solutions for optimal outcomes. Experience the BIOLASE difference and discover the limitless potential of laser dentistry. Dentists.Nov 29, 2023 · BIOLASE (BIOL) Stock Forecast & Price Target $1.10 -0.05 (-4.35%) (As of 11/29/2023 ET) Compare Today's Range $1.10 $1.20 50-Day Range $1.10 $1.89 52-Week Range $1.07 $99.50 Volume 88,335 shs Average Volume 156,585 shs Market Capitalization $2.53 million P/E Ratio N/A Dividend Yield N/A Price Target $77.00 capital one market captko group stock According to Biolase 's latest financial reports and stock price the company's current number of shares outstanding is 1,179,000. At the end of 2023 the ...According to 11 Wall Street analyst s that have issued a 1 year T price target, the average T price target is $18.32, with the highest T stock price forecast at $22.00 and the lowest T stock price forecast at $14.00. On average, Wall Street analysts predict that AT&T 's share price could reach $18.32 by Oct 23, 2024. cash app stocks list Stock BIOL November 24, 2023 NASDAQ 20 minutes delay $1.22 Open 1.27 Low ... BIOLASE is the global market leader in all-tissue & soft-tissue dental laser systems that are #AdvancingDentistry ...WebBIOLASE, Inc. (NASDAQ:BIOL) Q4 2022 Earnings Call Transcript March 28, ... GAAP net loss per share for the year 2022 was $4.13 compared to $2.73 in 2021 as adjusted for the reverse stock split.Shares of BIOLASE (NASDAQ: BIOL), a company that specializes in dental lasers, was up 20% in pre-market trading after it was granted a reprieve by the Nasdaq stock exchange.